Procedure
TaTME
TaTME is a medical procedure with 4 clinical trials. Currently 2 active trials ongoing.
Total Trials
4
Max Phase
—
Type
PROCEDURE
Molecule
—
Success Metrics
Active Trials
2(50%)
Phase Distribution
Ph phase_3
1
25%
Ph not_applicable
2
50%
Phase Distribution
0
Early Stage
0
Mid Stage
1
Late Stage
Phase Distribution3 total trials
Phase 3Large-scale testing
1(33.3%)
N/ANon-phased studies
2(66.7%)
Highest Phase Reached
Phase 3Trial Status & Enrollment
Completion Rate
0.0%
0 of 0 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
2
trials recruiting
Total Trials
4
all time
Status Distribution
Active(2)
Other(2)
Detailed Status
unknown2
Active, not recruiting1
Recruiting1
Development Timeline
Analytics
Development Status
Total Trials
4
Active
2
Success Rate
N/A
Most Advanced
Phase 3
Trials by Phase
Phase 31 (33.3%)
N/A2 (66.7%)
Trials by Status
unknown250%
active_not_recruiting125%
recruiting125%
Recent Activity
2 active trials
Showing 4 of 4
active_not_recruiting
Transanal Total Mesorectal Excision for Rectal Cancer on Anal Physiology + Fecal Incontinence
NCT03283540
recruitingnot_applicable
Transanal Versus Laparoscopic Total Mesorectal Excision for Rectal Cancer
NCT02966483
unknownnot_applicable
Abdominal or Transanal TME for Rectal Cancer Therapy
NCT04969107
unknownphase_3
COLOR III Trial: Transanal vs Laparoscopic TME
NCT02736942
Clinical Trials (4)
Showing 4 of 4 trials
NCT03283540
Transanal Total Mesorectal Excision for Rectal Cancer on Anal Physiology + Fecal Incontinence
NCT02966483Not Applicable
Transanal Versus Laparoscopic Total Mesorectal Excision for Rectal Cancer
NCT04969107Not Applicable
Abdominal or Transanal TME for Rectal Cancer Therapy
NCT02736942Phase 3
COLOR III Trial: Transanal vs Laparoscopic TME
All 4 trials loaded
Drug Details
- Intervention Type
- PROCEDURE
- Total Trials
- 4